Masayuki Kanamori, Shunji Mugikura, Osamu Iizuka, Naoko Mori, Yoshiteru Shimoda, Ichiyo Shibahara, Rei Umezawa, Keiichi Jingu, Ryuta Saito, Yukihiko Sonoda, et al. Clinical significance of cerebral microbleeds in patients with germinoma who underwent long-term follow-up. Journal of neuro-oncology. 2024. 170. 1. 173-184
Yuta Sekino, Yukihiko Sonoda, Ichiyo Shibahara, Junki Mizusawa, Keita Sasaki, Tetsuya Sekita, Mayumi Ichikawa, Hiroshi Igaki, Manabu Kinoshita, Toshihiro Kumabe, et al. Protocol digest of a phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery-hyperintense lesion on MRI for newly diagnosed supratentorial glioblastoma: JCOG2209 (FLAMINGO). Japanese journal of clinical oncology. 2024
Kazuya Motomura, Keita Sasaki, Narushi Sugii, Shigeru Yamaguchi, Hirotaka Inoue, Akito Oshima, Kazuhiro Tanaka, Yoshihiro Otani, Mitsuaki Shirahata, Ichiyo Shibahara, et al. Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group. Japanese journal of clinical oncology. 2024
Daisuke Yamamoto, Ichiyo Shibahara, Yuri Hyakutake, Madoka Inukai, Sumito Sato, Hiroyuki Koizumi, Takuichiro Hide, Toshihiro Kumabe. Complete removal of a cavernous malformation in the dorsal pons, in contact with the expanded transpontine vein: illustrative case. Journal of Neurosurgery: Case Lessons. 2024. 8. 8
Yukihiko Sonoda, Yuta Sekino, Junki Mizusawa, Ichiyo Shibahara, Keita Sasaki, Tetsuya Sekita, Mayumi Ichikawa, Hiroshi Igaki, Manabu Kinoshita, Junji Shibahara, et al. AB012. A phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery (FLAIR) hyperintensity lesion on magnetic resonance image for newly diagnosed supratentorial glioblastoma (JCOG2209). Chinese clinical oncology. 2024. 13. Suppl 1. AB012